Topics

Articles

Location serves as the US flagship for company’s global pharma development network.  




Project—which is expected to double plant’s distribution capacity—will be completed by end of Q3.



Complex to develop cGMP-compliant, commercial-scale plasmid DNA. 



Companies to release variety of options for this sector.

 


Expansion expected to help tackle health issues at a faster rate, company says




Transaction expected to close early this year




Creates Cellular Origins in order to simplify the late-stage development process




North Carolina facility to manufacture Pfizer’s pipeline products 




Nottingham location expected to be fully operational by the end of 2023




Platform is expected to streamline batch turnaround times


